DEE38
MCID: DVL064
MIFTS: 25
|
Developmental and Epileptic Encephalopathy 38 (DEE38)
Categories:
Cancer diseases, Ear diseases, Eye diseases, Fetal diseases, Genetic diseases, Liver diseases, Mental diseases, Metabolic diseases, Neuronal diseases, Rare diseases, Respiratory diseases
|
|
MalaCards integrated aliases for Developmental and Epileptic Encephalopathy 38:
Characteristics:OMIM®:57 (Updated 05-Mar-2021)
Inheritance:
autosomal recessive
Miscellaneous:
onset in infancy progressive disorder severe disorder death in early childhood (in some patients) HPO:31
developmental and epileptic encephalopathy 38:
Inheritance autosomal recessive inheritance Onset and clinical course infantile onset Classifications:
MalaCards categories:
Global: Genetic diseases Rare diseases Metabolic diseases Fetal diseases Cancer diseases Anatomical: Neuronal diseases Eye diseases Liver diseases Ear diseases Respiratory diseases Mental diseases |
OMIM® :
57
Developmental and epileptic encephalopathy-38 (DEE38) is an autosomal recessive neurologic and neurodegenerative disorder characterized by the onset of various type of seizures usually between about 4 and 7 months of age. Prior to the onset of seizures, most infants show severely impaired global development, hypotonia with poor head control, and visual inattention with roving eye movements and nystagmus. Seizures are usually refractory to treatment and associated with status epilepticus. Patients have little or no development with inability to walk or speak, spasticity or abnormal movements, and often cortical blindness. There is failure to thrive, and many require tube-feeding. Death in early childhood due to aspiration or intractable epilepsy may occur. The disorder is associated with a defect in GPI-anchoring of membrane-bound proteins (summary by Palmer et al., 2016; Davids et al., 2020).
For a general phenotypic description and a discussion of genetic heterogeneity of DEE, see 308350.
For a discussion of genetic heterogeneity of GPI biosynthesis defects, see GPIBD1 (610293). (617020) (Updated 05-Mar-2021)
MalaCards based summary : Developmental and Epileptic Encephalopathy 38, is also known as epileptic encephalopathy, early infantile, 38. An important gene associated with Developmental and Epileptic Encephalopathy 38 is ARV1 (ARV1 Homolog, Fatty Acid Homeostasis Modulator). Affiliated tissues include eye, bone and brain, and related phenotypes are retinal dystrophy and ataxia Disease Ontology : 12 A developmental and epileptic encephalopathy characterized by onset of seizures between 4 and 7 months of age, severely impaired global development, hypotonia with poor head control, and visual inattention that has material basis in homozygous or compound heterozygous mutation in the ARV1 gene on chromosome 1q42. UniProtKB/Swiss-Prot : 73 Epileptic encephalopathy, early infantile, 38: A form of epileptic encephalopathy, a heterogeneous group of severe childhood onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. EIEE38 inheritance is autosomal recessive. |
Human phenotypes related to Developmental and Epileptic Encephalopathy 38:31 (show all 9)
Symptoms via clinical synopsis from OMIM®:57 (Updated 05-Mar-2021)Clinical features from OMIM®:617020 (Updated 05-Mar-2021) |
|
MalaCards organs/tissues related to Developmental and Epileptic Encephalopathy 38:40
Eye,
Bone,
Brain
|
Articles related to Developmental and Epileptic Encephalopathy 38:
|
ClinVar genetic disease variations for Developmental and Epileptic Encephalopathy 38:6
UniProtKB/Swiss-Prot genetic disease variations for Developmental and Epileptic Encephalopathy 38:73
|
Search
GEO
for disease gene expression data for Developmental and Epileptic Encephalopathy 38.
|
|
|